BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Popov J, Caputi V, Nandeesha N, Rodriguez DA, Pai N. Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies. Int J Mol Sci 2021;22:11365. [PMID: 34768795 DOI: 10.3390/ijms222111365] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Su Y, Liang J, Zhang M, Zhao M, Xie X, Wang X, Pan Z, Huang S, Yan R, Wang Q, Zhou L, Luo X. Wogonin regulates colonocyte metabolism via PPARγ to inhibit Enterobacteriaceae against dextran sulfate sodium-induced colitis in mice. Phytother Res 2023;37:872-84. [PMID: 36451541 DOI: 10.1002/ptr.7677] [Reference Citation Analysis]
2 Laredo V, García-Mateo S, Martínez-Domínguez SJ, López de la Cruz J, Gargallo-Puyuelo CJ, Gomollón F. Risk of Cancer in Patients with Inflammatory Bowel Diseases and Keys for Patient Management. Cancers (Basel) 2023;15. [PMID: 36765829 DOI: 10.3390/cancers15030871] [Reference Citation Analysis]
3 Mazziotta C, Tognon M, Martini F, Torreggiani E, Rotondo JC. Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health. Cells 2023;12. [PMID: 36611977 DOI: 10.3390/cells12010184] [Reference Citation Analysis]
4 Shang Y, Zhai Z, Huang J, Li L, Zuo X. Specific alterations in mucosa-associated bacterial composition in ulcerative colitis (UC) patients with different degrees of inflammation. Biotechnology & Biotechnological Equipment 2022;36:200-8. [DOI: 10.1080/13102818.2022.2060134] [Reference Citation Analysis]
5 Bullard BM, VanderVeen BN, McDonald SJ, Cardaci TD, Murphy EA. Cross talk between the gut microbiome and host immune response in ulcerative colitis: nonpharmacological strategies to improve homeostasis. Am J Physiol Gastrointest Liver Physiol 2022;323:G554-61. [PMID: 36283090 DOI: 10.1152/ajpgi.00210.2022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Xiong S, Liu K, Yang F, Dong Y, Zhang H, Wu P, Zhou Y, Zhang L, Wu Q, Zhao X, Li W, Yuan L, Huang B, Yue R, Feng L, Chen J, Zhang Y. Global research trends on inflammatory bowel diseases and colorectal cancer: A bibliometric and visualized study from 2012 to 2021. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.943294] [Reference Citation Analysis]
7 Fan S, Xing J, Jiang Z, Zhang Z, Zhang H, Wang D, Tang D. Effects of Long Non-Coding RNAs Induced by the Gut Microbiome on Regulating the Development of Colorectal Cancer. Cancers (Basel) 2022;14. [PMID: 36497293 DOI: 10.3390/cancers14235813] [Reference Citation Analysis]
8 Tian H, Wen Z, Liu Z, Guo Y, Liu G, Sun B. Comprehensive analysis of microbiome, metabolome and transcriptome revealed the mechanisms of Moringa oleifera polysaccharide on preventing ulcerative colitis. Int J Biol Macromol 2022;222:573-86. [PMID: 36115453 DOI: 10.1016/j.ijbiomac.2022.09.100] [Reference Citation Analysis]
9 Quaglio AEV, Grillo TG, De Oliveira ECS, Di Stasi LC, Sassaki LY. Gut microbiota, inflammatory bowel disease and colorectal cancer. World J Gastroenterol 2022; 28(30): 4053-4060 [DOI: 10.3748/wjg.v28.i30.4053] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
10 Li M, Zhang R, Li J, Li J. The Role of C-Type Lectin Receptor Signaling in the Intestinal Microbiota-Inflammation-Cancer Axis. Front Immunol 2022;13:894445. [PMID: 35619716 DOI: 10.3389/fimmu.2022.894445] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Tsigalou C, Konstantinidis T, Aloizou A, Bezirtzoglou E, Tsakris A. Future Therapeutic Prospects in Dealing with Autoimmune Diseases: Treatment Based on the Microbiome Model. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases 2022. [DOI: 10.1007/978-981-19-4800-8_25] [Reference Citation Analysis]